Status:

COMPLETED

S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer

Lead Sponsor:

Kyoto University

Conditions:

Gastric Cancer

Eligibility:

All Genders

20+ years

Phase:

PHASE3

Brief Summary

RATIONALE: Drugs used in chemotherapy, such as S-1 and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more t...

Detailed Description

OBJECTIVES: Primary * Compare the overall survival of patients with potentially resectable stage III gastric cancer treated with neoadjuvant S-1 and cisplatin followed by gastrectomy and adjuvant S-...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed gastric adenocarcinoma, including type II or type III adenocarcinoma of the esophagogastric junction
  • Stage III disease
  • T3 or T4 and/or N2
  • No stage IV disease
  • Helical CT scan and laparoscopic staging required
  • Potentially resectable disease
  • PATIENT CHARACTERISTICS:
  • Age
  • 20 and over
  • Performance status
  • ECOG 0-1
  • Life expectancy
  • Not specified
  • Hematopoietic
  • WBC ≥ 4,000/mm³, but \< 12,000/mm³
  • Granulocyte count ≥ 2,000/mm³
  • Platelet count ≥ 100,000/mm³
  • Hemoglobin ≥ 9.0 g/dL
  • Hepatic
  • AST and ALT ≤ 2.5 times upper limit of normal
  • Bilirubin ≤ 1.5 mg/dL
  • Renal
  • Creatinine clearance ≥ 50 mL/min
  • Pulmonary
  • Arterial oxygen pressure (PaO\_2) ≥ 70 mm Hg on room air
  • Other
  • Able to take oral medications
  • PRIOR CONCURRENT THERAPY:
  • Biologic therapy
  • Not specified
  • Chemotherapy
  • No prior chemotherapy for gastric cancer
  • Endocrine therapy
  • Not specified
  • Radiotherapy
  • No prior radiotherapy for gastric cancer
  • Surgery
  • No prior surgery for gastric cancer
  • Other
  • No other prior therapy for gastric cancer

Exclusion

    Key Trial Info

    Start Date :

    April 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    November 1 2008

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT00182611

    Start Date

    April 1 2004

    End Date

    November 1 2008

    Last Update

    June 26 2013

    Active Locations (6)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (6 locations)

    1

    Fukui Red Cross Hospital

    Fukui-shi, Fukui, Japan, 918-8501

    2

    Kyoto University Hospital

    Kyoto, Kyoto, Japan, 606-8507

    3

    National Hospital Organization - Kyoto Medical Center

    Kyoto, Kyoto, Japan, 612-0861

    4

    Yamato Municipal Hospital

    Yamatotakada, Nara, Japan, 635-8501